information

..............page:430-431,433

Primary synovial sarcoma of pericardium:A case report
Rangreze Imran;Banday Manzoor Ahmad;Sheikh Aejaz Aziz;Bhat Salma;Mohammad Latif Charoo

..............page:428-429

The side effects of docetaxel with cyclophosphamide as postoperative adjuvant chemotherapy for elderly breast cancer patients
Lingqin Song;Yinbin Zhang;Jianjun He;Xijing Wang;Hongbing Ma;Wentao Xi;Liang Liang

..............page:391-393

Predictive biomarker and clinicopathological characteristics analysis for recurrence of early gastric cancer
Jiyuan Yang;Zhiqiang Cai;Wei Du;Junchuan Li;Tingxuan Chen;Yunhua Xu

..............page:394-398

Antiangiogenic therapy for breast cancer:current status and future perspectives
Yuan Wu;Weili Sun;Jifeng Feng

..............page:373-379

Renal impairment in multiple myelomas
Cheng Yang;Tianbiao Lan;Yi Cheng

..............page:418-422

Temozolomide plus rituximab for elderly with relapsed primary central nervous system lymphoma
Qingfeng Li;Gang Wu;Zhihua Sun;Jinghua Ren

..............page:415-417

Immunohistochemical study of nuclear factor-κB activity in colorectal cancer
Jin Li;Xiaonian Cao;Yu Deng;Junbo Hu;Jing Wang

..............page:406-409

Molecular targeted therapy in gastrointestinal cancer
Miao Xiang;Ximing Xu

..............page:380-385

Prospective comparative study of cool-tip radiofrequency ablation and surgical resection for hepatocellular carcinoma
Wentao Kong;Weiwei Zhang;Yudong Qiu;Tie Zhou;Han Bin

..............page:399-405

Prediction value of high-grade prostatic intraepithelial neoplasia for prostate cancer on repeat biopsies
Huilian Hou;Xu Li;Xingfa Chen;Chunbao Wang;Guanjun Zhang;Honghan Wang;Huilin Gong;Yuan Deng;Min Wang;Xuebin Zhang

..............page:410-414

COX-2 silencing inhibits cell proliferation in A549 cell
Weiying Li;Wentao Yue;Lina Zhang;Xiaoting Zhao;Li Ma;Xuehui Yang;Chunyan Zhang;Yue Wang;Meng Gu

..............page:423-427

Clinical study on gefitinib combined with γ-ray stereotactic radiotherapy for senile patients with adenocarcinoma of lung as the first-line regimen
Dejian Pan;Biao Wang;Xijian Zhou;Donglin Wang

..............page:386-390